Abstract
Antisense oligonucleotides (ASOs), a novel paradigm in modern therapeutics, modulate cellular gene expression by binding to complementary RNA sequences. Triantennary N-acetyl galactosamine (GN)-conjugated ASOs show greatly improved potency via Asialoglycoprotein receptor (ASGR)-mediated uptake in hepatocytes. Here, we compare the uptake kinetics and subsequent distribution of untargeted ASOs to that of GN-ASOs in mouse macrophages and hepatocytes using simultaneous coherent anti-Stokes Raman scattering (CARS) and two-photon excited fluorescence imaging. While the CARS modality captured the changing lipid distributions and overall morphology of the cell, two-photon fluorescence imaging measured the uptake and the subsequent distribution of the fluorescently labeled (Alexa-488) ASOs inside the cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
